OBJECTIVE-To determine whether alterations in counterregulatory responses to hypoglycemia through the modulation of ATP-sensitive K ϩ channels (K ATP channels) in the ventromedial hypothalamus (VMH) are mediated by changes in GABAergic inhibitory tone in the VMH, we examined whether opening and closing K ATP channels in the VMH alter local GABA levels and whether the effects of modulating K ATP channel activity within the VMH can be reversed by local modulation of GABA receptors.RESEARCH DESIGN AND METHODS-Rats were cannulated and bilateral guide cannulas inserted to the level of the VMH. Eight days later, the rats received a VMH microinjection of either 1) vehicle, 2) the K ATP channel opener diazoxide, 3) the K ATP channel closer glybenclamide, 4) diazoxide plus the GABA A receptor agonist muscimol, or 5) glybenclamide plus the GABA A receptor antagonist bicuculline methiodide (BIC) before performance of a hypoglycemic clamp. Throughout, VMH GABA levels were measured using microdialysis.RESULTS-As expected, diazoxide suppressed glucose infusion rates and increased glucagon and epinephrine responses, whereas glybenclamide raised glucose infusion rates in conjunction with reduced glucagon and epinephrine responses. These effects of K ATP modulators were reversed by GABA A receptor agonism and antagonism, respectively. Microdialysis revealed that VMH GABA levels decreased 22% with the onset of hypoglycemia in controls. Diazoxide caused a twofold greater decrease in GABA levels, and glybenclamide increased VMH GABA levels by 57%. T he established benefits of maintaining nearnormal blood glucose levels in patients with diabetes are limited by the risk of severe hypoglycemia (1,2). The problem is compounded by the fact that with each reoccurring episode of hypoglycemia, the body's ability to restore blood glucose levels to normal is compromised (3). Therefore, it is essential that we achieve a better understanding of how the body senses and activates defense mechanisms against hypoglycemia so that we can develop therapeutic strategies to more effectively prevent or minimize hypoglycemia in diabetic patients.
CONCLUSIONS-OurSpecific regions within the brain (4 -12) and periphery (13-15) have been shown to respond to changes in glucose concentrations. One brain region in particular, the ventromedial hypothalamus (VMH), contains glucose-responsive neurons that detect changes in ambient glucose levels and then alter their firing rate accordingly (5,6,16 -19). Two predominant subtypes of glucose-sensitive neurons exist within the brain: the glucose-excited neurons that increase and the glucose-inhibited neurons that decrease their firing rate as glucose levels rise (19,20). Kang et al. (18) have demonstrated that these neurons contain much of the same glucose-sensing machinery (e.g., glucokinase, ATPsensitive K ϩ channels [K ATP channels], etc.) as pancreatic -cells.The K ATP channels provide a close link between neuronal metabolism and the regulation of membrane potential in many tissues (21). K ATP channels are comp...